The latest health news includes Illumina's launch of affordable gene sequencers, Pfizer's promising cancer drug trials, CVS ...

Health-care companies rose as traders hedged their bets on the outlook for growth in the sector. Bayer shares fell sharply after Washington state's top court granted a petition for review in a case ...

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Researchers in China are testing an experimental 3D-printed breast prosthesis that can sense and target breast cancer relapse, according to a report in Advanced Science.

Real-time index price for TSX Smallcap Index (TXTW), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Annual National Conference was held Sep. 4-6 in Orlando, Florida. Managed Healthcare Executive is the official publication of ...

UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer. "GSK today ...

GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.